Asensus Surgical to Host Investor Day on February 21, 2023 30-01-2023, 19:01

Io Therapeutics, Inc., presented today results from studies of IRX4204, the company’s phase II clinical development stage, highly selective RXR nuclear receptor agonist compound, supporting its potential use for treatment of amyotrophic lateral sclerosis 16-07-2024, 20:26

WePlay Teams Up with Popular IP "NaiLoong" for a Triple Treat Summer Fiesta 4-08-2025, 11:00